Muscle toxicity (including myopathy and rhabdomyolysis) and liver enzyme elevations are the most well-recognized effects of statins, with 10–15% of patients reporting statin-associated muscle symptoms, and alanine aminotransferase (ALT) elevation may be observed in 0.5–2% of the subjects (31). The gene discussed is GPT; the disease is rhabdomyolysis.